Memorial Sloan Kettering Cancer Center
New York, United States
Joshua Budhu, MD, MS, MPH, is a neuro-oncologist and health equity researcher at Memorial Sloan Kettering Cancer Center in New York, NY, and the IDEAS (Inclusion, Diversity, Equity, Anti-racism, Social Justice) editor for the Neurology journal. Previously he was a clinical fellow in neuro-oncology at Massachusetts General Hospital, the Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, MA. Prior to fellowship, he served as Chief Resident in Neurology at MGH/BWH/HMS, the largest neurology residency in the country. Throughout his education and work experiences, he has demonstrated a commitment to improving health equity. Dr. Budhu aspires to affect change at the policy level through advocacy and awareness. His work focuses on improving access to care, eliminating barriers to care, and improving diversity in clinical trials. He serves on several national committees including the American Academy of Neurology’s Neuro-Oncology section. He co-authored op-eds for the Washington Post and Brookings Institution, denouncing the pseudoscientific concept “excited delirium”, which misappropriates medical terminology and is used to justify police brutality. He also writes articles for a wide audience about his experience as a physician and other health-related matters. Dr. Budhu received his medical degree from Morehouse School of Medicine in 2016 and his MPH from the Harvard T.H. Chan School of Public Health in 2022 as a Commonwealth Fund Fellow in Minority Health Policy at Harvard University.